Aesthetic device company Syneron Candela has announced its acquisition of Ellipse, a Danish medical device company that manufactures and markets intense pulsed light (IPL) and laser-based platforms.
Ellipse’s key products include Nordlys, a multi-application, multi-technology IPL and Nd:YAG device for vascular and pigmented lesions, and hair removal; as well as an IPL-only system which is used for skin rejuvenation, facial veins and hair removal.
Geoffrey Crouse, chief executive officer of Syneron Candela said of the announcement, “The acquisition of Ellipse allows Syneron Candela to strengthen its footprint in the multi-application space and provide our customers a comprehensive portfolio.” He continued, “Ellipse platforms will provide aesthetic practices with a fully scalable multi-application, multi-technology device. We look forward to Ellipse strengthening our portfolio as we continue to deliver our brand promise of science, results, trust to our physicians and patients worldwide.”
Chief executive officer at Ellipse, Jacob Kildegaard Larsen noted, “We are excited to join forces with Syneron Candela and market our strong technology platforms via Syneron Candela's expansive global footprint, along with its commitment to clinical excellence, quality and innovation.”